Syndax Pharmaceuticals, Inc. (SNDX)
20.79
+0.27
(+1.32%)
USD |
NASDAQ |
Jan 22, 16:00
20.78
-0.01
(-0.05%)
After-Hours: 17:34
Syndax Pharmaceuticals Free Cash Flow: -311.01M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arcutis Biotherapeutics, Inc. | -48.24M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Puma Biotechnology, Inc. | 42.87M |
| Krystal Biotech, Inc. | 165.59M |
| Sutro Biopharma, Inc. | -225.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -70.54M |
| Cash from Investing (Quarterly) | 72.43M |
| Cash from Financing (Quarterly) | 6.278M |
| Free Cash Flow Per Share (Quarterly) | -0.8158 |
| Free Cash Flow to Equity (Quarterly) | -70.57M |
| Free Cash Flow to Firm (Quarterly) | -62.38M |
| Free Cash Flow Yield | -17.35% |